Incyte and Cancer Support Community Delaware Announce the Establishment of the Incyte Cancer Care Assistance Fund for Delaware
Friday, 06 October 2017 03:06
Oct. 6, 2017 13:00 UTC

Incyte and Cancer Support Community Delaware Announce the Establishment of the Incyte Cancer Care Assistance Fund for Delaware

Fund to provide emergency financial support for Delaware cancer patients and their families

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq:INCY) and Cancer Support Community Delaware (CSCDE) today announced the establishment of the Incyte Cancer Care Assistance Fund for Delaware which will provide emergency financial assistance for cancer patients, their caregivers and family members living in Delaware.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171006005108/en/

Through the Incyte Charitable Giving Foundation, Incyte has committed to providing a maximum of $100,000 each year to CSCDE over the next 5 years, beginning in 2018.

“We are very pleased to announce the creation of the Incyte Cancer Care Assistance Fund for Delaware with Cancer Support Community Delaware, an organization which, like Incyte, is dedicated to supporting patients with cancer and the local community,” said Paula Swain, Executive Vice President of Human Resources and Chair of The Incyte Charitable Giving Foundation. “Today, as we celebrate the opening of our newly expanded headquarters in Wilmington, we reaffirm our commitment to Delaware and

to the well-being of the communities we serve.”

The fund will be administered by Cancer Support Community Delaware. Additional details about the Incyte Cancer Care Assistance Fund for Delaware will be made available in January 2018.

“Through the establishment of this fund, we aim to address the emergent needs that patients with cancer in Delaware face as they navigate their disease and

Error. Page cannot be displayed. Please contact your service provider for more details. (25)

its impact across all aspects of their lives,” said Nicole Topkis Pickles, Executive Director of Cancer Support Community Delaware.

About Cancer Support Community Delaware

The mission of Cancer Support Community Delaware is to ensure that all people impacted by cancer are empowered by knowledge, strengthened by action and

sustained by community. Through participation in professionally led support groups, educational workshops and mind/body classes, people affected by cancer learn vital skills that enable them to regain control, reduce isolation and restore hope regardless of the stage of disease. At Cancer Support Community Delaware, all programs are at no cost to cancer patients, caregivers and family members. More information about Cancer Support Community Delaware is available at www.cancersupportdelaware.org.

About the Incyte Charitable Giving Foundation

The Incyte Charitable Giving Foundation, part of Incyte Involved, the Company’s philanthropic and employee and community engagement program, provides charitable donations to publicly funded 501(c) (3) tax-exempt nonprofit organizations specifically serving the needs of communities in Delaware focused on two areas—Oncology Patient Support and Resources and Community Partnerships.

More information regarding Incyte Involved and the Incyte Charitable Giving Foundation, including the application process, funding guidelines, important information for applicants and quarterly submissions calendar, can be found here.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company’s website. Follow @Incyte on Twitter.

Forward-Looking Statements

Except for the historical information set forth herein, the matters set forth in this press release, including statements regarding the expectations for, and the focus of, the Incyte Charitable Giving Foundation, contain predictions, estimates and other forward-looking statements. These forward-looking statements are based on the Company’s current expectations and subject to risks and uncertainties that may cause actual results to differ materially, including, without limitation those risks detailed from time to time in the Incyte’s reports filed with the Securities and Exchange Commission, including its Form 10-Q for the quarter ended June 30, 2017. Incyte disclaims any intent or obligation to update these forward-looking statements.

Contacts

Incyte Corporation
Media
Catalina Loveman, +1 302-498-6171
cloveman@incyte.com
or
Investors
Michael Booth, DPhil, +1 302-498-5914
mbooth@incyte.com


Source: Incyte Corporation and Cancer Support Community Delaware (CSCDE)

Smart Multimedia Gallery

View this news release and multimedia online at:
http://www.businesswire.com/news/home/20171006005108/en




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 
BMR:1